News / Africa

Malaria: New Partnership Aims to Stop Parasite in its Tracks

Multimedia

Audio
Joe DeCapua

A new partnership is being launched to develop a malaria vaccine that would prevent parasites from entering the liver.  Most of the symptoms of the disease develop after parasites have had time to replicate there.

A new partnership is being launched to develop a malaria vaccine that would prevent parasites from entering the liver.  Most of the symptoms of the disease develop after parasites have had time to replicate there.

The World Health Organization estimates that in 2008, there were 247 million cases of malaria worldwide, with one million deaths.  It says in Africa, a child dies every 45 seconds from the disease.

The best treatment now available is artemisinin-based combination therapy.  But an effective vaccine would be much better.  That’s the goal of the partnership involving the international, non-profit organization PATH, Merck Pharmaceuticals and New York University.

Finding a weakness

Scientists think they’ve discovered the Achilles heel of the malaria parasite.  After a bite by an infected mosquito, the parasite travels through the bloodstream and arrives at the liver.  That’s where scientists believe the best line of defense can be made.

Dr. Ashley Birkett is PATH’s Malaria Vaccine Initiative director of pre and early clinical development.

“The parasite has a natural affinity for liver cells.  Liver cells are the cells that the parasite can actually make copies of itself in once it enters the human body.  So, it’s goal once it enters the human bloodstream after an infectious bite is to find liver cells.  And then it enters those liver cells through a set of specific interactions that we don’t fully understand.  But there is a critical event in that entry process that we think we can target through a vaccine approach,” he says.

He says if the parasite cannot enter the liver, it cannot replicate and cause disease.  But targeting a parasite is more difficult than targeting viruses or bacteria.

“This is a parasite,” he says, “It’s a very complex organism that has over 5,000 different gene products that it makes.  It’s a lot more complicated than a typical virus.  I think also there have been limited resources that have been applied to malaria vaccine development over the years.  But we are having significant success now.  And through a partnership with GlaxoSmithKline, PATH MVI is engaged in a very large phase-three clinical study, which is a last stage of clinical testing before a vaccine can actually be licensed and start saving lives.”

Birkett says the vaccine has been evaluated in 16,000 young children in seven sub-Saharan African countries.  It has an efficacy rate of 50 percent.

“So, given that we’re looking in the order of 900,000 deaths from malaria in young children primarily per year in sub-Saharan Africa, a vaccine with 50 percent efficacy is actually a very significant achievement.  But we want to do better,” says Birkett.

The vaccine being tested depends on the body producing very large numbers of antibodies against the malaria parasite. That’s makes it more difficult to have a higher efficacy rate.  The hope of a new vaccine is to specifically target a different area of the parasite with fewer anti-bodies.

Malaria taking a toll

Dr. Birkett says this would relieve African countries of some heavy burdens.

“We’re looking at countries in sub-Saharan Africa, which already have significant burdens to deal with in terms of economic impact of these global infectious diseases.  And malaria has a huge economic impact.  So a vaccine that can be highly protective and prevent these clinical diseases and up to 900,000 deaths per year is going to have a significant health and economic benefit in these countries,” he says.

Dr. Birkett says the cost of such a vaccine would be kept as low as possible.  Clinical testing on the proposed vaccine is still three or four years away.   Malaria immunization would be included as part of a child’s routine vaccinations.

You May Like

Reports of Mass Murder on Mediterranean Smuggler’s Boat

Boat sailed from Libya with 750 migrants aboard and arrived in Italy with 569 More

Video New Thailand Hotline Targets Misbehaving Monks

Officials say move aims to restore country’s image of Buddhism, tarnished by recent high profile scandals such as opulent lifestyle, drug and alcohol abuse, as well as child sex abuse More

Study: Dust from Sahara Helped Form Bahama Islands

What does the Sahara have in common with a Caribbean island? Quite a lot, researchers say More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Astronauts Train in Underwater Labi
X
George Putic
July 25, 2014 7:25 PM
In the world’s only underwater laboratory, four U.S. astronauts train for a planned visit to an asteroid. The lab - called Aquarius- is located five kilometers off Key Largo, in southern Florida. Living in close quarters and making excursions only into the surrounding ocean, they try to simulate the daily routine of a crew that will someday travel to collect samples of a rock orbiting far away from earth. VOA’s George Putic has more.
Video

Video Astronauts Train in Underwater Lab

In the world’s only underwater laboratory, four U.S. astronauts train for a planned visit to an asteroid. The lab - called Aquarius- is located five kilometers off Key Largo, in southern Florida. Living in close quarters and making excursions only into the surrounding ocean, they try to simulate the daily routine of a crew that will someday travel to collect samples of a rock orbiting far away from earth. VOA’s George Putic has more.
Video

Video Not Even Monks Spared From Thailand’s Junta-Backed Morality Push

With Thailand’s military government firmly in control after May’s bloodless coup, authorities are carrying out plans they say are aimed at restoring discipline, morality and patriotism to all Thais. The measures include a crackdown on illegal gambling, education reforms to promote students’ moral development, and a new 24-hour phone hotline for citizens to report misbehaving monks. Steve Sandford reports from Bangkok.
Video

Video Virtual Program Teaches Farming Skills

In a fast-changing world beset by unpredictable climate conditions, farmers cannot afford to ignore new technology. Researchers in Australia are developing an online virtual world program to share information about climate change and more sustainable farming techniques for sugar cane growers. As VOA's Zlatica Hoke reports, the idea is to create a wider support network for farmers.
Video

Video Airline Expert: Missile will Show Signature on Debris

The debris field from Malaysia Airlines Flight 17 is spread over a 21-kilometer radius in eastern Ukraine. It is expected to take investigators months to sort through the airplane pieces to learn about the missile that brought down the jetliner and who fired it. VOAs Carolyn Presutti explains how this work will be done.
Video

Video Treatment for Childhood Epilepsy Heats up Medical Marijuana Debate

In the United States, marijuana is classed as an illegal drug by the federal government. But nearly half the states have legalized it, to some degree. Proponents say some strains of marijuana might have exceptional health benefits, for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. Shelley Schlender reports on a strain of medical marijuana developed in Colorado that is reputed to reduce seizures in childhood epilepsy
Video

Video Airbus Adds Metal 3D Printed Parts to New Jets

By the end of this year, European aircraft manufacturing consortium Airbus plans to deliver the first of its new, extra-wide-body passenger jets, the A350-XWB. Among other technological innovations, the new plane will also incorporate metal parts made in a 3-D printer. VOA's George Putic has more.
Video

Video AIDS Conference Welcomes Exciting Developments in HIV Treatment, Prevention

Significant strides have been made in recent years toward the treatment and prevention of HIV, the virus that causes AIDS. This year, at the International AIDS Conference, the AIDS community welcomed progress on a new pill that may prevent transmission of the deadly virus. VOA’s Anita Powell reports from Melbourne, Australia.
Video

Video IAEA: Iran Turns its Enriched Uranium Into Less Harmful Form

Iran has converted its stockpiles of enriched uranium into a less dangerous form that is more difficult to use for nuclear weapons, according to the United Nations’ Atomic Energy Agency. The move complies with an interim deal reached with Western powers on Iran's nuclear program last year, in exchange for easing of sanctions. Henry Ridgwell reports for VOA from London.

AppleAndroid